| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |